Get the Stockscreener App
23.45
0.34%
0.08
After Hours:
23.45
Lifemd Inc stock is traded at $23.45, with a volume of 3,870.
It is up +0.34% in the last 24 hours and up +6.83% over the past month.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
See More
Previous Close:
$23.37
Open:
$22.885
24h Volume:
3,870
Relative Volume:
1.75
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.67%
1M Performance:
+6.83%
6M Performance:
+5.16%
1Y Performance:
+6.59%
1-Day Range:
$22.89
$23.75
1-Week Range:
$21.91
$23.75
52-Week Range:
$20.25
$25.00
Lifemd Inc Stock (LFMDP) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
866 351 5907
Address
236 Fifth Avenue, Suite 400, New York
Compare LFMDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMDP
Lifemd Inc
|
23.45 | 0 | 0 | 0 | 0 | 0.00 |
|
WBA
Walgreens Boots Alliance Inc
|
11.26 | 9.74B | 147.66B | -8.64B | -363.00M | -10.01 |
|
HITI
High Tide Inc
|
2.19 | 177.17M | 376.07M | -22.41M | 18.73M | -0.298 |
|
WGRX
Wellgistics Health Inc
|
2.67 | 138.69M | 0 | 0 | 0 | 0.00 |
|
PETS
Petmed Express Inc
|
4.02 | 83.04M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
SCNX
Scienture Holdings Inc
|
1.24 | 11.15M | 0 | 0 | 0 | 0.00 |
Lifemd Inc Stock (LFMDP) Latest News
LifeMD stock target raised to $14 by H.C. Wainwright - Investing.com Canada
LifeMD Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
LifeMD’s (LFMD) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
Cantor Fitzgerald maintains LifeMD stock at Overweight, $15 target By Investing.com - Investing.com Australia
LifeMD, Inc. Reports Strong Telehealth Growth Amid Challenges - TipRanks
LifeMD, Inc. SEC 10-K Report - TradingView
LifeMD Inc. (LFMD) reports earnings - Quartz
LifeMD, Inc. (NASDAQ:LFMD) Q4 2024 Earnings Call Transcript - Insider Monkey
Top Premarket Gainers -March 11, 2025 at 07:54 am EDT - Marketscreener.com
KeyBanc maintains Overweight rating on LifeMD shares By Investing.com - Investing.com South Africa
KeyBanc maintains Overweight rating on LifeMD shares - Investing.com
LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions - Yahoo Finance
LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Reven - GuruFocus.com
Earnings call transcript: LifeMD beats Q4 2024 expectations, stock surges By Investing.com - Investing.com Canada
LifeMD, Inc. Reports Strong Q4 2024 Results - TipRanks
LifeMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LifeMD reports Q4 EPS 21c vs. 14c last year - TipRanks
LifeMD Inc Outlook Q1 2025 Total Revenue In The Range Of $61 Million To $63 Million - Marketscreener.com
Earnings call transcript: LifeMD beats Q4 2024 expectations, stock surges - Investing.com
LifeMD Q4 Revenue USD 64.3 Million Versus. Ibes Estimate USD 57.4 Million -March 10, 2025 at 05:31 pm EDT - Marketscreener.com
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
LifeMD Reports Fourth Quarter 2024 Results - GlobeNewswire
LifeMD earnings beat by $0.26, revenue topped estimates - Investing.com Canada
LifeMD Reports Fourth Quarter 2024 Results - GlobeNewswire Inc.
LIFEMD Earnings Results: $LFMD Reports Quarterly Earnings - Nasdaq
LifeMD stock soars 16% on earnings beat, strong guidance By Investing.com - Investing.com Canada
LifeMD options imply 11.7% move in share price post-earnings - TipRanks
When Would Be The Best Time To Buy LifeMD Inc (NASDAQ: LFMD) Stock? - Stocks Register
LifeMD, Inc. (NASDAQ:LFMD) Receives $11.14 Average PT from Brokerages - Defense World
Rhumbline Advisers Raises Stock Position in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks - Simply Wall St
LifeMD Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
LifeMD, Inc. (LFMD): A Bull Case Theory - MSN
LifeMD Inc (LFMD) Q4 2024: Everything You Need to Know Ahead of Earnings - GuruFocus.com
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound - MSN
LifeMD and Teladoc Health partner with LillyDirect pharmacy provider Gifthealth for Zepbound - MSN
Two telehealth firms turn to branded Zepbound as restrictions loom on copies - Reuters.com
Teladoc, LifeMD partner with Eli Lilly on GLP-1s - Modern Healthcare
LifeMD announces integration with LillyDirect pharmacy provider - TipRanks
LifeMD Integrates With LillyDirect to Offer Access of Single-dose Vials of Zepbound - MarketWatch
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound - Marketscreener.com
LifeMD to Offer Zepbound Through LillyDirect Partnership -March 06, 2025 at 08:43 am EST - Marketscreener.com
LifeMD integrates with Gifthealth for obesity treatment access - Investing.com India
LifeMD® Announces Integration with LillyDirect Pharmacy - GlobeNewswire
Can LifeMD's New Lilly Partnership Transform Patient Access to Zepbound? - StockTitan
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum - GlobeNewswire
Can LifeMD's Upcoming Investor Presentation Reveal New Growth Strategies? - StockTitan
Lifemd Inc Stock (LFMDP) Financials Data
There is no financial data for Lifemd Inc (LFMDP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.66%
1.42%
Cap:
|
Volume (24h):